In contrast, in a clinical study conducted on 170 patients in China by Sun et al. [37], circulating levels of total Chol and LDL were markedly higher in patients with triple-negative and HER2-positive breast cancer than in luminal A- and B-negative patients. This evidence concerns the gene ERBB2 and breast cancer.